Claritev Corporation (CTEV) - Total Assets

Latest as of June 2026: $4.76 Billion USD

Based on the latest financial reports, Claritev Corporation (CTEV) holds total assets worth $4.76 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Claritev Corporation - Total Assets Trend (2019–2025)

This chart illustrates how Claritev Corporation's total assets have evolved over time, based on quarterly financial data. Also see CTEV market cap overview for the company's overall valuation and market capitalisation.

Claritev Corporation - Asset Composition Analysis

Current Asset Composition (December 2025)

Claritev Corporation's total assets of $4.76 Billion consist of 4.6% current assets and 95.4% non-current assets. Review CTEV total liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 0.3%
Accounts Receivable $138.18 Million 2.8%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $1.88 Billion 38.6%
Goodwill $2.41 Billion 49.2%

Asset Composition Trend (2019–2025)

This chart illustrates how Claritev Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See CTEV stock price and chart for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Claritev Corporation's current assets represent 4.6% of total assets in 2025, an increase from 1.4% in 2019.
  • Cash Position: Cash and equivalents constituted 0.3% of total assets in 2025, up from 0.3% in 2019.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 87.0% of total assets, a decrease from 95.0% in 2019.
  • Asset Diversification: The largest asset category is goodwill at 49.2% of total assets.

Claritev Corporation Competitors by Total Assets

Key competitors of Claritev Corporation based on total assets are shown below.

Company Country Total Assets
Singular Health Group Ltd
AU:SHG
Australia AU$12.55 Million
NexgenRX Inc.
V:NXG
Canada CA$39.20 Million
Intrasense
PA:ALINS
France €7.99 Million
Medadvisor Ltd
AU:MDR
Australia AU$39.84 Million
HITIQ Ltd
AU:HIQ
Australia AU$3.28 Million
Pro Medicus Ltd
AU:PME
Australia AU$533.91 Million
ARTRYA Ltd
AU:AYA
Australia AU$92.19 Million
Cogstate Ltd
AU:CGS
Australia AU$64.77 Million

Claritev Corporation - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.00 0.98 1.83
Quick Ratio 1.00 0.98 1.83
Cash Ratio 0.00 0.00 0.00
Working Capital $-1.09 Million $-6.00 Million $139.02 Million

Claritev Corporation - Advanced Valuation Insights

This section examines the relationship between Claritev Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 43.86
Latest Market Cap to Assets Ratio 0.11
Asset Growth Rate (YoY) -5.1%
Total Assets $4.89 Billion
Market Capitalization $525.24 Million USD

Valuation Analysis

Below Book Valuation: The market values Claritev Corporation's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Claritev Corporation's assets decreased by 5.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Claritev Corporation (2019–2025)

The table below shows the annual total assets of Claritev Corporation from 2019 to 2025.

Year Total Assets Change
2025-12-31 $4.89 Billion -5.09%
2024-12-31 $5.15 Billion -26.04%
2023-12-31 $6.96 Billion -5.51%
2022-12-31 $7.37 Billion -10.33%
2021-12-31 $8.22 Billion -0.76%
2020-12-31 $8.28 Billion -0.92%
2019-12-31 $8.36 Billion --

About Claritev Corporation

NYSE:CTEV USA Health Information Services
Market Cap
$525.24 Million
Market Cap Rank
#12095 Global
#3027 in USA
Share Price
$30.81
Change (1 day)
-2.90%
52-Week Range
$13.47 - $71.36
All Time High
$72.58
About

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary n… Read more